Comparative Risk of Serious Infections With Tumor Necrosis Factor α Antagonists vs Vedolizumab in Patients With Inflammatory Bowel Diseases
| Autor: | Singh, Siddharth, Heien, Herbert C., Herrin, Jeph, Dulai, Parambir S., Sangaralingham, Lindsey, Shah, Nilay D., Sandborn, William J. |
|---|---|
| Zdroj: | In Clinical Gastroenterology and Hepatology February 2022 20(2):e74-e88 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|